Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor–driven Programs-Reference-Cited by-同舟云学术

Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor–driven Programs

Published:2023-11 Issue:5 Volume:84 Page:455-460
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Linder Simon,Severson Tesa M.,van der Mijn Koen J.C.,Nevedomskaya Ekaterina,Siefert Joseph C.,Stelloo Suzan,Pomerantz Mark M.,Freedman Matthew L.,van der Poel Henk,Jerónimo Carmen,Henrique Rui,Bergman Andries M.,Zwart Wilbert

Publisher

Elsevier BV

Subject

Urology

Reference10 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging;Gleason;J Urol,1974

3. Do adenocarcinomas of the prostate with Gleason score (GS) ≤6 have the potential to metastasize to lymph nodes?;Ross;Am J Surg Pathol,2012

4. Androgen receptor enhancer usage and the chromatin regulatory landscape in human prostate cancers;Stelloo;Endocr Relat Cancer,2019

5. Integrative epigenetic taxonomy of primary prostate cancer;Stelloo;Nat Commun,2018

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Inherited Allele Confers Prostate Cancer Progression and Drug Resistance via RFX6/HOXA10‐Orchestrated TGFβ Signaling;Advanced Science;2024-06-26

2. Re: Outcomes of Biopsy Grade Group 1 Prostate Cancer Diagnosis in the Danish Population;European Urology;2024-06

3. Re: BilR is a Gut Microbial Enzyme that Reduces Bilirubin to Urobilinogen;European Urology;2024-06

4. Disrupting prostate cancer research: Challenge accepted; report from the 2023 Coffey‐Holden Prostate Cancer Academy Meeting;The Prostate;2024-04-29

5. RFX6 at locus 6q22 confers metastasis and drug resistance in prostate cancer;2024-01-09